|
CN103732611A
|
|
Use of beta-adrenergic inverse agonists for smoking cessation
|
|
WO2008002929A2
|
|
Heterologous cross-sensitization for improved agonist activity
|
|
AU2006269944A1
|
|
Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
|
|
US2006194882A1
|
|
Method of treating airway diseases with beta-adrenergic inverse agonists
|
|
CA2544733A1
|
|
Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists
|
|
US2007276024A1
|
|
Methods for Treating Diseases and Conditions with Inverse Agonists and for Screening for Agents Acting as Inverse Agonists
|
